文献速递鼻科

利多卡因/去氧肾上腺素鼻喷雾与雾化给药在鼻内镜检查前的随机对照试验

Lidocaine/Phenylephrine Nasal Spray versus Nebulization Prior to Nasoendoscopy: A Randomized Controlled Trial.
PubMed 文献 · Otolaryngol Head Neck Surg · 2018-08-21

这项开放标签多中心随机对照试验纳入106例未治疗慢性鼻炎患者,比较鼻雾化器与鼻喷雾给予400 μL利多卡因/去氧肾上腺素后的鼻腔减充血效果。雾化组在5、15、30分钟时鼻腔阻力低于喷雾组,干预后疼痛评分亦显著降低,提示雾化给药减充血与镇痛效果更佳。

要点

  • 鼻雾化给予利多卡因/去氧肾上腺素在5、15、30分钟时鼻腔阻力低于鼻喷雾。
  • 雾化组干预后下鼻甲加压疼痛评分显著低于喷雾组。
  • 内镜医师主观评估亦支持雾化组鼻腔减充血程度更佳。

核心结论

  • 与鼻喷雾相比,经鼻雾化器给予利多卡因/去氧肾上腺素可获得更好的减充血和镇痛效果。

研究设计与样本

  • 开放标签随机对照试验,多中心研究,共纳入106例未治疗慢性鼻炎参与者,53例经鼻雾化器、53例经鼻喷雾向右鼻孔给予400 μL利多卡因/去氧肾上腺素,左侧鼻孔为对照。

主要发现

  • 右鼻孔鼻腔阻力在雾化给药后总体低于鼻喷雾,但仅在5分钟(P = .047)、15分钟(P = .016)和30分钟(P = .036)差异有统计学意义。
  • 内镜医师对鼻腔的主观评估支持雾化组减充血程度更佳(P = .001)。
  • 干预后疼痛评分显示雾化组较喷雾组疼痛阈值显著下降(P = .040)。

关键数值与推荐

  • 鼻腔阻力于干预后5、10、15、30分钟以主动前鼻测压法在150-Pa固定压力下评估。
  • 疼痛评分于干预后30分钟通过对下鼻甲施加压力主观评估。

临床怎么用

  • 鼻内镜检查前需鼻腔减充血时,可优先考虑经鼻雾化器给予利多卡因/去氧肾上腺素以改善减充血与镇痛。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective To objectively compare the nasal decongestion potency of lidocaine/phenylephrine when delivered with a nasal nebulizer and a nasal spray before a rigid nasoendoscopic examination. Study Design Open-label randomized controlled trial. Setting Multicenter study. Methods This prospective clinical trial involved 106 participants with untreated chronic rhinitis. Fifty-three participants had 400 μL of lidocaine/phenylephrine administered into the right nostril with a nasal nebulizer, while the remaining 53 participants had 400 μL administered with a nasal spray. The control was the left nostril. Nasal resistance at 150-Pa fixed pressure was evaluated with an active anterior rhinomanometry at 5, 10, 15, and 30 minutes postintervention. Pain score was assessed subjectively by applying pressure to the inferior turbinate 30 minutes after intervention. Results There was an overall reduction in nasal resistance of the right nostril when lidocaine/phenylephrine was administered with the nasal nebulizer in comparison with the nasal spray. However, a statistically significant difference in nasal resistance was seen only at 5 minutes ( P = .047), 15 minutes ( P = .016), and 30 minutes ( P = .036). The examining endoscopist further supported the degree of nasal decongestion via subjective assessment of the nasal cavity ( P = .001). Pain scores obtained after the intervention showed a significant decrease in pain threshold when the nasal nebulizer was used instead of the nasal spray ( P = .040). Conclusions This study suggests that the delivery of lidocaine/phenylephrine to the nasal cavity by the nasal nebulizer provides better decongestive and analgesic potency as compared with the delivery by nasal sprays.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Goh LC, Arvin B, Zulkiflee AB, et al. Lidocaine/Phenylephrine Nasal Spray versus Nebulization Prior to Nasoendoscopy: A Randomized Controlled Trial. Otolaryngol Head Neck Surg. 2018. PMID: 30126325. doi:10.1177/0194599818795852

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。